Resveratrol and cancer: Focus on in vivo evidence

Endocrine-Related Cancer

Volumn 21, Issue 3, 2014, Pages

  Carter, Lindsay G ^a   D'Orazio, John A ^a   Pearson, Kevin J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Colon; Mammary gland; Obesity; Phytoestrogen; Prostate

Indexed keywords

DIETHYLNITROSAMINE; DIMETHYLBENZ[A]ANTHRACENE; METHYLNITROSOUREA; PHYTOESTROGEN; POLYPHENOL; RESVERATROL; ANTINEOPLASTIC AGENT; STILBENE DERIVATIVE;

AGING; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER PREVENTION; CANCER RISK; CELL CYCLE ARREST; COLON CANCER; DIET SUPPLEMENTATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; LIVER CANCER; NONHUMAN; OBESITY; PANCREAS CANCER; PROSTATE CANCER; REVIEW; RISK REDUCTION; TUMOR MODEL; TUMOR VOLUME; ANIMAL; NEOPLASMS;

ANIMALS; ANTINEOPLASTIC AGENTS; HUMANS; NEOPLASMS; STILBENES;

EID: 84899463978     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0171     Document Type: Review

References (135)

1. Afaq F, Adhami VM & Ahmad N 2003 Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. Toxicology and Applied Pharmacology 186 28-37. (doi:10.1016/S0041-008X(02)00014-5)
2. Alfaras I, Juan ME & Planas JM 2010 Tans-resveratrol reduces precancerous colonic lesions in dimethylhydrazine-treated rats. Journal of Agricultural and Food Chemistry 58 8104-8110. (doi:10.1021/jf100702x)
3. Alter MJ 2007 Epidemiology of hepatitis C virus infection. World Journal of Gastroenterology 13 2436-2441. (Pubitemid 46929498)
4. Andlauer W, Kolb J, Siebert K & Furst P 2000 Assessment of resveratrol bioavailability in the perfused small intestine of the rat. Drugs Under Experimental and Clinical Research 26 47-55. (Pubitemid 30352884)
5. Aziz MH, Reagan-Shaw S, Wu J, Longley BJ & Ahmad N 2005 Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? FASEB Journal 19 1193-1195. (Pubitemid 40946462)
6. Baghurst PA, McMichael AJ, Slavotinek AH, Baghurst KI, Boyle P & Walker AM 1991 A case-control study of diet and cancer of the pancreas. American Journal of Epidemiology 134 167-179.
7. Banerjee S, Bueso-Ramos C & Aggarwal BB 2002 Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-κB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Research 62 4945-4954. (Pubitemid 34984418)
8. Baur JA & Sinclair DA 2006 Therapeutic potential of resveratrol: the in vivo evidence. Nature Reviews. Drug Discovery 5 493-506. (doi:10.1038/ nrd2060) (Pubitemid 44136961)
9. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K et al. 2006 Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 337-342.(doi:10.1038/ nature05354) (Pubitemid 44764104)
10. Benitez DA, Hermoso MA, Pozo-Guisado E, Fernandez-Salguero PM & Castellon EA 2009 Regulation of cell survival by resveratrol involves inhibition of NFkB-regulated gene expression in prostate cancer cells. Prostate 69 1045-1054. (doi:10.1002/pros.20953)
11. Bhat KP & Pezzuto JM 2002 Cancer chemopreventive activity of resveratrol. Annals of the New York Academy of Sciences 957 210-229. (doi:10.1111/j.1749-6632.2002.tb02918.x) (Pubitemid 34721666)
12. Bhat KP, Lantvit D, Christov K, Mehta RG, Moon RC & Pezzuto JM 2001 Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Research 61 7456-7463. (Pubitemid 32995034)
13. Bhatt JK, Thomas S & Nanjan MJ 2012 Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutrition Research 32 537-541. (doi:10.1016/j.nutres.2012.06.003)
14. Bishayee A & Dhir N 2009 Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis. Chemico-Biological Interactions 179 131-144. (doi:10.1016/j.cbi.2008.11.015)
15. Bishayee A, Barnes KF, Bhatia D, Darvesh AS & Carroll RT 2010a Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis. Cancer Prevention Research 3 753-763. (doi:10.1158/1940-6207.CAPR-09-0171)
16. Bishayee A, Waghray A, Barnes KF, Mbimba T, Bhatia D, Chatterjee M & Darvesh AS 2010b Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis. Pharmaceutical Research 27 1080-1091. (doi:10.1007/s11095-010-0144-4)
17. Bove K, Lincoln DW& Tsan MF 2002 Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo. Biochemical and Biophysical Research Communications 291 1001-1005. (doi:10.1006/bbrc.2002.6554) (Pubitemid 34694375)
18. Bowers JL, Tyulmenkov VV, Jernigan SC & Klinge CM 2000 Resveratrol acts as a mixed agonist/antagonist for estrogen receptors a and b. Endocrinology 141 3657-3667.
19. Bradamante S, Barenghi L & Villa A 2004 Cardiovascular protective effects of resveratrol. Cardiovascular Drug Reviews 22 169-188. (doi:10.1111/j.1527-3466.2004.tb00139.x) (Pubitemid 39391187)
20. Brasnyo P, Molnar GA, Mohas M, Marko L, Laczy B, Cseh J, Mikolas E, Szijarto IA, Merei A, Halmai R et al. 2011 Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. British Journal of Nutrition 106 383-389. (doi:10.1017/S0007114511000316)
21. Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G et al. 2010 Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Research 70 9003-9011. (doi:10.1158/0008-5472. CAN-10-2364)
22. Burns J, Yokota T, Ashihara H, Lean ME & Crozier A 2002 Plant foods and herbal sources of resveratrol. Journal of Agricultural and Food Chemistry 50 3337-3340. (doi:10.1021/jf0112973) (Pubitemid 34533643)
23. Calle EE, Rodriguez C, Walker-Thurmond K & Thun MJ 2003 Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. New England Journal of Medicine 348 1625-1638. (doi:10.1056/ NEJMoa021423) (Pubitemid 36459468)
24. Carbo N, Costelli P, Baccino FM, Lopez-Soriano FJ & Argiles JM 1999 Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochemical and Biophysical Research Communications 254 739-743. (doi:10.1006/bbrc.1998.9916) (Pubitemid 29290538)
25. Castillo-Pichardo L, Cubano LA & Dharmawardhane S 2013 Dietary grape polyphenol resveratrol increases mammary tumor growth and metastasis in immunocompromised mice. BMC Complementary and Alternative Medicine 13 6. (doi:10.1186/1472-6882-13-6)
26. Chatterjee M, Das S, Janarthan M & Ramachandran HK 2011 Role of 5-lipoxygenase in resveratrol mediated suppression of 7,12-dimethylbenz(α) anthracene-induced mammary carcinogenesis in rats. European Journal of Pharmacology 668 99-106. (doi:10.1016/j.ejphar.2011.06.039)
27. Chow HH, Garland LL, Hsu CH, Vining DR, Chew WM, Miller JA, Perloff M, Crowell JA & Alberts DS 2010 Resveratrol modulates drug-and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prevention Research 3 1168-1175. (doi:10.1158/1940-6207.CAPR-09-0155)
28. Clement MV, Hirpara JL, Chawdhury SH & Pervaiz S 1998 Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92 996-1002. (Pubitemid 28355484)
29. Crandall JP, Oram V, Trandafirescu G, Reid M, Kishore P, Hawkins M, Cohen HW & Barzilai N 2012 Pilot study of resveratrol in older adults with impaired glucose tolerance. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 67 1307-1312. (doi:10.1093/gerona/glr235)
30. Csaki C, Mobasheri A & Shakibaei M 2009 Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1β-induced NF-κB-mediated inflammation and apoptosis. Arthritis Research & Therapy 11 R165. (doi:10.1186/ar2850)
31. Dennis T, FanousM& Mousa S 2009 Natural products for chemopreventive and adjunctive therapy in oncologic disease. Nutrition and Cancer 61 587-597. (doi:10.1080/01635580902825530)
32. De Santi C, Pietrabissa A, Spisni R, Mosca F & Pacifici GM 2000 Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids. Xenobiotica 30 857-866. (doi:10.1080/ 004982500433282)
33. DeSantis C, Howlader N, Cronin KA & Jemal A 2011a Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidemiology, Biomarkers & Prevention 20 733-739. (doi:10.1158/1055-9965.EPI-11-0061)
34. DeSantis C, Siegel R, Bandi P & Jemal A 2011b Breast cancer statistics, 2011. CA: A Cancer Journal for Clinicians 61 409-418. (doi:10.3322/caac.20134)
35. Dias SJ, Li K, Rimando AM, Dhar S, Mizuno CS, Penman AD & Levenson AS 2013 Trimethoxy-resveratrol and piceatannol administered orally suppress and inhibit tumor formation and growth in prostate cancer xenografts. Prostate 73 1135-1146. (doi:10.1002/pros.22657)
36. Doll R & Peto R 1981 The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. Journal of the National Cancer Institute 66 1191-1308. (Pubitemid 11063920)
37. Dong Z 2003 Molecular mechanism of the chemopreventive effect of resveratrol. Mutation Research 523-524 145-150. (doi:10.1016/S0027-5107(02) 00330-5) (Pubitemid 36293241)
38. El-Serag HB, Hampel H & Javadi F 2006 The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clinical Gastroenterology and Hepatology 4 369-380. (doi:10.1016/j.cgh.2005.12.007) (Pubitemid 43343895)
39. Galanis DJ, Kolonel LN, Lee J & Le Marchand L 1998 Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii, United States. Cancer Causes & Control 9 217-224. (doi:10.1023/A:1008842613331) (Pubitemid 28160977)
40. Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L & Dyer A 2000 Abnormal glucose metabolism and pancreatic cancer mortality. Journal of American Medical Association 283 2552-2558. (doi:10.1001/jama.283.19.2552) (Pubitemid 30324198)
41. Garvin S, Ollinger K & Dabrosin C 2006 Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Letters 231 113-122. (doi:10.1016/j.canlet.2005.01.031) (Pubitemid 41779459)
42. Goldberg DM, Yan J, Ng E, Diamandis EP, Karumanchiri A, Soleas G & Waterhouse AL 1995 A global survey of trans-resveratrol concentrations in commercial wines. American Journal of Enology and Viticulture 46 159-165.
43. Goldberg DM, Yan J & Soleas GJ 2003 Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clinical Biochemistry 36 79-87. (doi:10.1016/S0009-9120(02)00397-1) (Pubitemid 36126394)
44. Harikumar KB, Kunnumakkara AB, Sethi G, Diagaradjane P, Anand P, Pandey MK, Gelovani J, Krishnan S, Guha S & Aggarwal BB 2010 Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. International Journal of Cancer 127 257-268.
45. Harper CE, Patel BB, Wang J, Arabshahi A, Eltoum IA & Lamartiniere CA 2007 Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis 28 1946-1953. (doi:10.1093/carcin/bgm144) (Pubitemid 47500607)
46. Holmes-McNary M & Baldwin AS Jr 2000 Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkB kinase. Cancer Research 60 3477-3483. (Pubitemid 30482167)
47. Howells LM, Berry DP, Elliott PJ, Jacobson EW, Hoffmann E, Hegarty B, Brown K, Steward WP & Gescher AJ 2011 Phase I randomized, doubleblind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases-safety, pharmacokinetics, and pharmacodynamics. Cancer Prevention Research 4 1419-1425. (doi:10.1158/1940-6207.CAPR-11-0148)
48. Hung LM, Chen JK, Huang SS, Lee RS & Su MJ 2000 Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovascular Research 47 549-555. (doi:10.1016/S0008-6363(00)00102-4)
49. Jacoby RF, Marshall DJ, Newton MA, Novakovic K, Tutsch K, Cole CE, Lubet RA, Kelloff GJ, Verma A, Moser AR et al. 1996 Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Research 56 710-714.
50. Jacoby RF, Seibert K, Cole CE, Kelloff G & Lubet RA 2000 The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Research 60 5040-5044.
51. Jang M & Pezzuto JM 1999 Cancer chemopreventive activity of resveratrol. Drugs Under Experimental and Clinical Research 25 65-77. (Pubitemid 29257597)
52. JangM, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG et al. 1997 Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 218-220. (doi:10.1126/science.275.5297.218) (Pubitemid 127696281)
53. Johnson JJ, Nihal M, Siddiqui IA, Scarlett CO, Bailey HH, Mukhtar H & Ahmad N 2011 Enhancing the bioavailability of resveratrol by combining it with piperine. Molecular Nutrition & Food Research 55 1169-1176. (doi:10.1002/mnfr.201100117)
54. Kaldas MI, Walle UK & Walle T 2003 Resveratrol transport and metabolism by human intestinal Caco-2 cells. Journal of Pharmacy and Pharmacology 55 307-312. (doi:10.1211/002235702612) (Pubitemid 36410351)
55. Kalra N, Roy P, Prasad S & Shukla Y 2008 Resveratrol induces apoptosis involving mitochondrial pathways in mouse skin tumorigenesis. Life Sciences 82 348-358. (doi:10.1016/j.lfs.2007.11.006)
56. Kang L, Heng W, Yuan A, Baolin L & Fang H 2010 Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: relative to inhibition of inflammatory responses. Biochimie 92 789-796. (doi:10.1016/j.biochi.2010.02.024)
57. Kang W, Hong HJ, Guan J, Kim DG, Yang EJ, Koh G, Park D, Han CH, Lee YJ & Lee DH 2012 Resveratrol improves insulin signaling in a tissuespecific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents. Metabolism 61 424-433. (doi:10.1016/j.metabol.2011.08.003)
58. Khan N, Afaq F & Mukhtar H 2008 Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxidants & Redox Signaling 10 475-510. (doi:10.1089/ars.2007.1740)
59. Kinghorn AD, Su BN, Jang DS, Chang LC, Lee D, Gu JQ, Carcache-Blanco EJ, Pawlus AD, Lee SK, Park EJ et al. 2004 Natural inhibitors of carcinogenesis. Planta Medica 70 691-705. (doi:10.1055/s-2004-827198) (Pubitemid 39178928)
60. Kiraly-Veghely Z, Tyihak E, Albert L, Nemeth ZI & Katay G 1998 Identification and measurement of resveratrol and formaldehyde in parts of white and blue grape berries. Acta Biologica Hungarica 49 281-289. (Pubitemid 29456257)
61. Kopp P 1998 Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? European Journal of Endocrinology 138 619-620. (doi:10.1530/eje.0. 1380619)
62. Kundu JK & Surh YJ 2008 Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Letters 269 243-261. (doi:10.1016/j.canlet.2008.03.057)
63. Kuroiwa Y, Nishikawa A, Kitamura Y, Kanki K, Ishii Y, Umemura T & Hirose M 2006 Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters. Cancer Letters 241 275-280. (doi:10.1016/j.canlet.2005.10.028) (Pubitemid 44163037)
64. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P et al. 2006 Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1a. Cell 127 1109-1122. (doi:10.1016/j.cell.2006.11.013) (Pubitemid 44894520)
65. Langcake P & Pryce RJ 1976 Production of resveratrol by vitis-vinifera and other members of vitaceae as a response to infection or injury. Physiological Plant Pathology 9 77-86. (doi:10.1016/0048-4059(76)90077- 1)
66. Le Corre L, Chalabi N, Delort L, Bignon YJ & Bernard-Gallon DJ 2005 Resveratrol and breast cancer chemoprevention: molecular mechanisms. Molecular Nutrition & Food Research 49 462-471. (doi:10.1002/mnfr.200400094) (Pubitemid 40780393)
67. Lee KW & Lee HJ 2006 The roles of polyphenols in cancer chemoprevention. BioFactors 26 105-121. (doi:10.1002/biof.5520260202)
68. Lin HC, Chen YF, Hsu WH, Yang CW, Kao CH & Tsai TF 2012 Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model. Cancer Prevention Research 5 952-962. (doi:10.1158/1940-6207.CAPR-12-0001)
69. Llovet JM, Burroughs A & Bruix J 2003 Hepatocellular carcinoma. Lancet 362 1907-1917. (doi:10.1016/S0140-6736(03)14964-1) (Pubitemid 37518510)
70. Luther DJ, Ohanyan V, Shamhart PE, Hodnichak CM, Sisakian H, Booth TD, Meszaros JG & Bishayee A 2011 Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma. Investigational New Drugs 29 380-391. (doi:10.1007/s10637-009-9332-7)
71. Lyons MM, Yu C, Toma RB, Cho SY, Reiboldt W, Lee J & van Breemen RB 2003 Resveratrol in raw and baked blueberries and bilberries. Journal of Agricultural and Food Chemistry 51 5867-5870. (doi:10.1021/jf034150f)
72. MacCarrone M, Lorenzon T, Guerrieri P & Agro AF 1999 Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. European Journal of Biochemistry 265 27-34. (doi:10.1046/j.1432-1327. 1999.00630.x) (Pubitemid 29466009)
73. Majumdar AP, Banerjee S, Nautiyal J, Patel BB, Patel V, Du J, Yu Y, Elliott AA, Levi E & Sarkar FH 2009 Curcumin synergizes with resveratrol to inhibit colon cancer. Nutrition and Cancer 61 544-553. (doi:10.1080/ 01635580902752262)
74. Moller H, Mellemgaard A, Lindvig K & Olsen JH 1994 Obesity and cancer risk: a Danish record-linkage study. European Journal of Cancer 30A 344-350. (doi:10.1016/0959-8049(94)90254-2) (Pubitemid 24152476)
75. Moon RT, Kohn AD, De Ferrari GV & Kaykas A 2004 WNT and β-catenin signalling: diseases and therapies. Nature Reviews. Genetics 5 691-701. (doi:10.1038/nrg1427) (Pubitemid 39150127)
76. Murakami A, Matsumoto K, Koshimizu K & Ohigashi H 2003 Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide-and interferon-g-induced IkB degradation in RAW264.7 macrophages. Cancer Letters 195 17-25. (doi:10.1016/S0304-3835(03)00058-2) (Pubitemid 36588974)
77. Nakagawa H, Kiyozuka Y, Uemura Y, Senzaki H, Shikata N, Hioki K & Tsubura A 2001 Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator. Journal of Cancer Research and Clinical Oncology 127 258-264. (doi:10.1007/s004320000190)
78. Newhauser WD & Durante M 2011 Assessing the risk of second malignancies after modern radiotherapy. Nature Reviews. Cancer 11 438-448. (doi:10.1038/nrc3069)
79. Nguyen AV, Martinez M, Stamos MJ, Moyer MP, Planutis K, Hope C & Holcombe RF 2009 Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Management and Research 1 25-37.
80. Oi N, Jeong CH, Nadas J, Cho YY, Pugliese A, Bode AM & Dong Z 2010 Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A(4)hydrolase. Cancer Research 70 9755-9764. (doi:10.1158/0008-5472. CAN-10-2858)
81. Olsen GW, Mandel JS, Gibson RW, Wattenberg LW & Schuman LM 1989 A case-control study of pancreatic cancer and cigarettes, alcohol, coffee and diet. American Journal of Public Health 79 1016-1019. (doi:10.2105/AJPH.79.8. 1016)
82. Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA et al. 2010 Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Research 70 7392-7399. (doi:10.1158/0008-5472.CAN-10-2027)
83. Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E et al. 2008 Resveratrol delays agerelated deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metabolism 8 157-168. (doi:10.1016/j.cmet.2008.06.011)
84. Pervaiz S 2003 Resveratrol: from grapevines to mammalian biology. FASEB Journal 17 1975-1985. (doi:10.1096/fj.03-0168rev) (Pubitemid 37392442)
85. Popat R, Plesner T, Davies F, Cook G, Cook M, Elliott P, Jacobson E, Gumbleton T, Oakervee H & Cavenagh J 2013 A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma. British Journal of Haematology 160 714-717. (doi:10.1111/bjh.12154)
86. Poulsen MM, Vestergaard PF, Clasen BF, Radko Y, Christensen LP, Stodkilde-Jorgensen H, Moller N, Jessen N, Pedersen SB & Jorgensen JO 2013 High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes 62 1186-1195. (doi:10.2337/db12- 0975)
87. Provinciali M, Re F, Donnini A, Orlando F, Bartozzi B, Di Stasio G & Smorlesi A 2005 Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. International Journal of Cancer 115 36-45. (doi:10.1002/ijc.20874) (Pubitemid 40559666)
88. Rajasekaran D, Elavarasan J, Sivalingam M, Ganapathy E, Kumar A, Kalpana K & Sakthisekaran D 2011 Resveratrol interferes with N-nitrosodiethylamine- induced hepatocellular carcinoma at early and advanced stages in male Wistar rats. Molecular Medicine Reports 4 1211-1217.
89. Ramadori G, Gautron L, Fujikawa T, Vianna CR, Elmquist JK & Coppari R 2009 Central administration of resveratrol improves diet-induced diabetes. Endocrinology 150 5326-5333. (doi:10.1210/en.2009-0528)
90. Reagan-Shaw S, Afaq F, Aziz MH & Ahmad N 2004 Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin. Oncogene 23 5151-5160. (doi:10.1038/sj.onc.1207666) (Pubitemid 38980348)
91. Reagan-Shaw S, Nihal M & Ahmad N 2008 Dose translation from animal to human studies revisited. FASEB Journal 22 659-661. (doi:10.1096/fj.07-9574LSF) (Pubitemid 351348146)
92. Reen RK, Jamwal DS, Taneja SC, Koul JL, Dubey RK, Wiebel FJ & Singh J 1993 Impairment of UDP-glucose dehydrogenase and glucuronidation activities in liver and small intestine of rat and guinea pig in vitro by piperine. Biochemical Pharmacology 46 229-238. (doi:10.1016/0006-2952(93)90408-O) (Pubitemid 23218606)
93. Renaud S & de Lorgeril M 1992 Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339 1523-1526. (doi:10.1016/0140-6736(92)91277-F)
94. Roy P, Madan E, Kalra N, Nigam N, George J, Ray RS, Hans RK, Prasad S & Shukla Y 2009 Resveratrol enhances ultraviolet B-induced cell death through nuclear factor-κB pathway in human epidermoid carcinoma A431 cells. Biochemical and Biophysical Research Communications 384 215-220. (doi:10.1016/j.bbrc.2009.04.100)
95. Roy SK, Chen Q, Fu J, Shankar S & Srivastava RK 2011 Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors. PLoS ONE 6 e25166. (doi:10.1371/journal.pone.0025166)
96. Salado C, Olaso E, Gallot N, Valcarcel M, Egilegor E, Mendoza L & Vidal-Vanaclocha F 2011 Resveratrol prevents inflammation-dependent hepatic melanoma metastasis by inhibiting the secretion and effects of interleukin-18. Journal of Translational Medicine 9 59. (doi:10.1186/1479-5876-9-59)
97. Sale S, Tunstall RG, Ruparelia KC, Potter GA, Steward WP & Gescher AJ 2005 Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4 0-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(MinC) mouse and cyclooxygenase-2 in human-derived colon cancer cells. International Journal of Cancer 115 194-201. (doi:10.1002/ijc. 20884) (Pubitemid 40586727)
98. Sancho E, Batlle E & Clevers H 2004 Signaling pathways in intestinal development and cancer. Annual Review of Cell and Developmental Biology 20 695-723. (doi:10.1146/annurev.cellbio.20.010403.092805) (Pubitemid 39488655)
99. Sanders TH, McMichael RW Jr & Hendrix KW 2000 Occurrence of resveratrol in edible peanuts. Journal of Agricultural and Food Chemistry 48 1243-1246. (doi:10.1021/jf990737b) (Pubitemid 30243692)
100. Sato M, Pei RJ, Yuri T, Danbara N, Nakane Y & Tsubura A 2003 Prepubertal resveratrol exposure accelerates N-methyl-N-nitrosourea-induced mammary carcinoma in female Sprague-Dawley rats. Cancer Letters 202 137-145. (doi:10.1016/j.canlet.2003.08.016) (Pubitemid 37485886)
101. Schneider Y, Duranton B, Gosse F, Schleiffer R, Seiler N & Raul F 2001 Resveratrol inhibits intestinal tumorigenesis and modulates hostdefense-related gene expression in an animal model of human familial adenomatous polyposis. Nutrition and Cancer 39 102-107. (doi:10.1207/ S15327914nc391-14) (Pubitemid 32880955)
102. Seehusen DA, Baird D & Bode D 2010 Primary care of adult survivors of childhood cancer. American Family Physician 81 1250-1255.
103. Seeni A, Takahashi S, Takeshita K, Tang M, Sugiura S, Sato SY & Shirai T 2008 Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model. Asian Pacific Journal of Cancer Prevention 9 7-14.
104. Sengottuvelan M & Nalini N 2006 Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development. British Journal of Nutrition 96 145-153. (doi:10.1079/BJN20061789) (Pubitemid 44160908)
105. Sengottuvelan M, Deeptha K & Nalini N 2009 Influence of dietary resveratrol on early and late molecular markers of 1,2-dimethylhydrazine-induced colon carcinogenesis. Nutrition 25 1169-1176. (doi:10.1016/j.nut.2009.03.009)
106. Shankar S, Nall D, Tang SN,Meeker D, Passarini J, Sharma J & Srivastava RK 2011 Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS ONE 6 e16530. (doi:10.1371/journal.pone.0016530)
107. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R & Srinivas PS 1998 Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica 64 353-356. (doi:10.1055/s-2006-957450) (Pubitemid 28234275)
108. Shukla Y & Singh R 2011 Resveratrol and cellular mechanisms of cancer prevention. Annals of the New York Academy of Sciences 1215 1-8. (doi:10.1111/j.1749-6632.2010.05870.x)
109. Siegel R, Naishadham D & Jemal A 2012 Cancer statistics, 2012. CA: A Cancer Journal for Clinicians 62 10-29. (doi:10.3322/caac.20138)
110. Siegel R, Naishadham D & Jemal A 2013 Cancer statistics, 2013. CA: A Cancer Journal for Clinicians 63 11-30. (doi:10.3322/caac.21166)
111. Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, Brown LM, Hayes RB, Swanson GM, Schoenberg JB, Pottern LM et al. 1998 Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. Journal of the National Cancer Institute 90 1710-1719. (doi:10.1093/jnci/90.22.1710) (Pubitemid 28539090)
112. Singh CK, George J & Ahmad N 2013 Resveratrol-based combinatorial strategies for cancer management. Annals of the New York Academy of Sciences 1290 113-121. (doi:10.1111/nyas.12160)
113. Soleas GJ, Angelini M, Grass L, Diamandis EP & Goldberg DM 2001 Absorption of trans-resveratrol in rats. Methods in Enzymology 335 145-154. (Pubitemid 32507234)
114. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto JM & Dannenberg AJ 1998 Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. Journal of Biological Chemistry 273 21875-21882. (doi:10.1074/jbc.273.34. 21875) (Pubitemid 28405365)
115. Szekeres T, Saiko P, Fritzer-Szekeres M, Djavan B & Jager W 2011 Chemopreventive effects of resveratrol and resveratrol derivatives. Annals of the New York Academy of Sciences 1215 89-95. (doi:10.1111/j.1749-6632.2010. 05864.x)
116. Tatlidede E, Sehirli O, Velioglu-Ogunc A, Cetinel S, Yegen BC, Yarat A, Suleymanoglu S & Sener G 2009 Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage. Free Radical Research 43 195-205. (doi:10.1080/10715760802673008)
117. Tessitore L, Davit A, Sarotto I & Caderni G 2000 Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 21 1619-1622. (doi:10.1093/carcin/21.8.1619) (Pubitemid 30608219)
118. Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S et al. 2011 Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metabolism 14 612-622. (doi:10.1016/j.cmet.2011.10.002)
119. Tome-Carneiro J, Gonzalvez M, Larrosa M, Yanez-Gascon MJ, Garcia-Almagro FJ, Ruiz-Ros JA, Garcia-Conesa MT, Tomas-Barberan FA&Espin JC 2012 One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease. American Journal of Cardiology 110 356-363. (doi:10.1016/j.amjcard.2012.03.030)
120. Tome-Carneiro J, Larrosa M, Gonzalez-Sarrias A, Tomas-Barberan FA, Garcia-Conesa MT & Espin JC 2013 Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Current Pharmaceutical Design 19 6064-6093. (doi:10.2174/138161281131 99990407)
121. Trentham-Dietz A, Newcomb PA, Egan KM, Titus-Ernstoff L, Baron JA, Storer BE, Stampfer M & Willett WC 2000 Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes & Control 11 533-542. (doi:10.1023/A:1008961931534) (Pubitemid 30342842)
122. Tsai SH, Lin-Shiau SY & Lin JK 1999 Suppression of nitric oxide synthase and the down-regulation of the activation of NFkB in macrophages by resveratrol. British Journal of Pharmacology 126 673-680. (doi:10.1038/sj.bjp. 0702357)
123. Vainio H, Kaaks R & Bianchini F 2002 Weight control and physical activity in cancer prevention: international evaluation of the evidence. European Journal of Cancer 11 (Suppl 2) S94-S100. (Pubitemid 35265868)
124. Vastano BC, Chen Y, Zhu N, Ho CT, Zhou Z & Rosen RT 2000 Isolation and identification of stilbenes in two varieties of Polygonum cuspidatum. Journal of Agricultural and Food Chemistry 48 253-256. (doi:10.1021/jf9909196) (Pubitemid 30120350)
125. Walle T, Hsieh F, DeLegge MH, Oatis JE Jr & Walle UK 2004 High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabolism and Disposition 32 1377-1382. (doi:10.1124/dmd.104.000885) (Pubitemid 39564557)
126. Wang TT, Hudson TS, Wang TC, Remsberg CM, Davies NM, Takahashi Y, Kim YS, Seifried H, Vinyard BT, Perkins SN et al. 2008 Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis 29 2001-2010. (doi:10.1093/carcin/bgn131)
127. Wechter WJ, Murray ED Jr, Kantoci D, Quiggle DD, Leipold DD, Gibson KM & McCracken JD 2000 Treatment and survival study in the C57BL/6JAPC(Min)/ C(Min) mouse with R-flurbiprofen. Life Sciences 66 745-753. (doi:10.1016/S0024- 3205(99)00645-1) (Pubitemid 30077867)
128. Wenzel E & Somoza V 2005 Metabolism and bioavailability of trans-resveratrol. Molecular Nutrition & Food Research 49 472-481. (doi:10.1002/mnfr.200500010) (Pubitemid 40780394)
129. Whitsett T, Carpenter M & Lamartiniere CA 2006 Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats. Journal of Carcinogenesis 5 15. (doi:10.1186/1477-3163-5-15)
130. Willett WC 1995 Diet, nutrition, and avoidable cancer. Environmental Health Perspectives 103 (Suppl 8) 165-170. (doi:10.1289/ehp.95103s8165)
131. Wolk A 2005 Diet, lifestyle and risk of prostate cancer. Acta Oncologica 44 277-281. (doi:10.1080/02841860510029572) (Pubitemid 40904131)
132. Yang K, Popova NV, Yang WC, Lozonschi I, Tadesse S, Kent S, Bancroft L, Matise I, Cormier RT, Scherer SJ et al. 2008 Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation. Cancer Research 68 7313-7322. (doi:10.1158/0008-5472.CAN-08-0598)
133. Yoshino J, Conte C, Fontana L, Mittendorfer B, Imai S, Schechtman KB, Gu C, Kunz I, Rossi Fanelli F, Patterson BW et al. 2012 Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metabolism 16 658-664. (doi:10.1016/j.cmet.2012.09.015)
134. Yu C, Shin YG, Chow A, Li Y, Kosmeder JW, Lee YS, Hirschelman WH, Pezzuto JM,Mehta RG & van Breemen RB 2002 Human, rat, and mouse metabolism of resveratrol. Pharmaceutical Research 19 1907-1914. (doi:10.1023/A:1021414129280) (Pubitemid 36016041)
135. Ziegler CC, Rainwater L, Whelan J & McEntee MF 2004 Dietary resveratrol does not affect intestinal tumorigenesis in Apc(Min/C) mice. Journal of Nutrition 134 5-10. (Pubitemid 38057415)